29786-42-3 Usage
Description
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is a chemical compound characterized by its molecular formula C13H10F3N. It is a cyclobutane derivative featuring a carbonitrile functional group, along with a trifluoromethyl group and a phenyl group attached to the cyclobutane ring. This unique structure endows the compound with potentially interesting chemical properties and reactivity.
Uses
Used in Organic Synthesis:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as an intermediate in organic synthesis for its structural features and potential reactivity, which can be exploited to create a variety of other compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as a building block for the development of new drugs, leveraging its unique structural properties to design molecules with specific biological activities.
Used in Materials Science:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is also used in materials science as a component in the development of novel materials, taking advantage of its structural characteristics to enhance material properties such as strength, flexibility, or chemical resistance.
(Note: The specific uses and properties of 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile would need to be determined through further research and testing, as the provided materials do not detail its exact applications.)
Check Digit Verification of cas no
The CAS Registry Mumber 29786-42-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,7,8 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 29786-42:
(7*2)+(6*9)+(5*7)+(4*8)+(3*6)+(2*4)+(1*2)=163
163 % 10 = 3
So 29786-42-3 is a valid CAS Registry Number.
29786-42-3Relevant articles and documents
Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same
-
Paragraph 1569-1572, (2017/07/18)
The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017
Propionamide compounds as antiinflammatory agents
-
Page/Page column 4; 7, (2010/11/27)
The present invention relates to compounds of formula I: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof The invention also relates to methods of using the compounds of formula I a
